This federal contract award to Prolacta Bioscience, Inc. is for the delivery of pre-natal formula and food supplements to the Defense Health Agency (DHA), a component of the U.S. Department of Defense. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price, valued at $114,925.60. The period of performance extends through September 27, 2024. This contract is not associated with any set-aside programs. Prolacta Bioscience, a for-profit manufacturer of human milk-based nutritional products, has previously been awarded numerous contracts from the DHA and Army Medical Command to provide a range of specialized items to support premature and critically ill infants at military treatment facilities across the United States.
Generated 10/1/24, 11:11 AM